Which of the following is included among the recommendations for managing NSAID-induced peptic ulcers?

Utilization of proton pump inhibitors (PPIs) is a well-established recommendation for managing NSAID-induced peptic ulcers. PPIs work by significantly reducing gastric acid secretion, which helps to promote healing of the ulcerated tissue in the gastrointestinal tract. By lowering acid levels, PPIs not only alleviate pain associated with ulceration but also create an environment that is conducive to the healing process.

In the context of NSAID-induced peptic ulcers, where the use of nonsteroidal anti-inflammatory drugs can compromise the gastric mucosal barrier and contribute to damage, PPIs effectively mitigate the harmful effects of continued NSAID use. They provide a protective effect by promoting ulcer healing and preventing the recurrence of ulcers in patients who may need to continue NSAID therapy for conditions such as arthritis or chronic pain.

The other options do not align with the standard management practices for NSAID-induced peptic ulcers. For instance, systemic steroids may exacerbate gastric irritation, increased dietary fiber is generally not directly effective for ulcer treatment, and wholesale discontinuation of all medications might not be practical or necessary in managing the patient's overall condition.